Tracking the latest developments from across the health sciences industry
Home 9 News
FDA Issues EUA for Vela Diagnostics COVID-19 PCR Test

The FDA issued yesterday (8/5) Emergency Use Authorization for Vela Diagnostics for the manual version of their COVID-19 PCR test. The manual version of the test enables flexible sample processing, facilitating widespread use of the test throughout the United States....

Novartis Receives Approval For Enzair Breezhaler

The European Commission (EC) has granted approval for Novartis’ Enzair Breezhaler, a drug therapy for uncontrolled asthma. The drug is utilized as a maintenance treatment for adults with asthma. “Novartis is working to reimagine medicine for people with uncontrolled...


CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: